Skip to main content

Susan Berson and Brent Henry Recognized as Health Care Trailblazers by the National Law Journal

Filter by:

News Thumbnail Mintz
Law360 featured the arrival of leading trial lawyer John C. Dougherty as a Member in Mintz’s Litigation Practice in Boston. The article highlighted Mr. Dougherty’s life sciences industry focus, and included his commentary on what drew him to Mintz, citing the firm’s multidisciplinary, collaborative approach to client service and focus on growth.
News Thumbnail Mintz
The American Lawyer published an article highlighting Mintz’s strong financials from fiscal year 2020, marking its sixth consecutive year of revenue increase. The article included commentary from Mintz Managing Member Bob Bodian on the firm’s success, which he credited to its strategic plan and focus on core practice groups, including life sciences. In addition to 2020 financials, the article detailed Mintz’s focus on adding laterals across practices and offices, and noted select high profile matters and pro bono work around racial and social justice. The article also captured how Mintz was able to achieve these outstanding results during the pandemic without conducting layoffs or furloughs for the firm’s roughly 1,200 attorneys and professional staff.
News Thumbnail Mintz
Mintz Member Andrew Skale was quoted in an article published by The New York Times on trademark issues related to the anticipated name change of Cleveland’s professional baseball team in response to nationwide social reform efforts. Specifically, Mr. Skale offered insights for those launching new products, emphasizing the importance of filing with the U.S. Patent and Trademark Office prior to making any public announcements to avoid trademark squatting, a process in which individuals or companies try to predict valuable names and file trademarks to sell for profit.
News Thumbnail Mintz
Mintz Member Joanne S. Hawana was quoted in an analysis article published by Law360 on the biggest COVID-19 product scams and actions taken by the U.S. Food and Drug Administration (FDA) to tackle fraudsters during the ongoing crisis.

Follow Mintz